Hepatitis C Biopump Trials Get Green Light | Hepatitis Central

The latest research & treatment news about Hepatitis C infection, diagnosis, symptoms and treatment.

Menu Search
Previous

Concerns Halt Idenix Hep C Drug

Back to News Homepage
Next

New Therapy Protects Chimps from Hep C Virus

Hepatitis C Biopump Trials Get Green Light

The Editors at Hepatitis Central
September 4, 2012

Print this page

In Israel, Medgenics has been approved to deliver a naturally-produced interferon alpha for Hepatitis C via a biopump in trials for treatment naïve patients and those who have previously relapsed.

Timing Couldn’t Be Better for First Human Clinical Trials of Biopump Technology for Hepatitis C

* Reuters is not responsible for the content in this press release.

Thu Aug 30, 2012 6:20am EDT

In a leap forward for viral medicine no less important than the first studies in HIV decades ago, Medgenics, Inc. (AMEX:MDGN) is set to begin two human clinical trials for its INFRADURE Biopump to test a continuous release of naturally-produced interferon alpha for hepatitis C.

This may, perhaps someday pit it against widely-used PEG-interferon/ribavirin with its host of highly unpleasant side effects such as debilitating flu-like symptoms, depression, bloody diarrhea, and a potential for developing Type 2 diabetes.

Continue reading this entire article:
http://www.reuters.com/article/2012/08/30/idUS105781+30-Aug-2012+HUG20120830

No Comments - be the first!
Share
Share
Previous

Concerns Halt Idenix Hep C Drug

Back to News Homepage
Next

New Therapy Protects Chimps from Hep C Virus

Requirements for using and reposting articles

Comments

HepatitisCentral.com provides information regarding hepatitis and liver disease. Comments are available to the community in order to discuss these topics and obtain answers to questions through community members. The Editors at HepatitisCentral.com will not be responding to questions or comments posed in article comments.